Visualitza per autor "Schenker, Michael"
Ara mostrant els elements 1-2 d 2
-
First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
Paz-Ares, Luis; Bennouna, Jaafar; Schenker, Michael; Cheng, Ying; FELIP, ENRIQUETA; Cobo, Manuel; Ciuleanu, Tudor Eliade (Elsevier, 2023-02) -
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
Carbone, David; Ciuleanu, Tudor Eliade; Bordenave, Stéphanie; Juan-Vidal, Oscar; Schenker, Michael; cobo, manuel; FELIP, ENRIQUETA (BMJ, 2024-02)